Browse
Submit Data
Databases
API
Help

Dataset Information

10 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

From small structural modifications to adjustment of structurally dependent properties: 1-methyl-3,5-bis[(E)-2-thienylidene]-4-piperidone and 3,5-bis[(E)-5-bromo-2-thienylidene]-1-methyl-4-piperidone.

ABSTRACT: The molecules of the title compounds, C(16)H(15)NOS(2), (I), and C(16)H(13)Br(2)NOS(2), (II), are E,E-isomers and consist of an extensive conjugated system, which determines their molecular geometries. Compound (I) crystallizes in the monoclinic space group P2(1)/c. It has one thiophene ring disordered over two positions, with a minor component contribution of 0.100 (3). Compound (II) crystallizes in the noncentrosymmetric orthorhombic space group Pca2(1) with two independent molecules in the unit cell. These molecules are related by a noncrystallographic pseudo-inversion center and possess very similar geometries. The crystal packings of (I) and (II) have a topologically common structural motif, viz. stacks along the b axis, in which the molecules are bound by weak C-H...O hydrogen bonds. The noncentrosymmetric packing of (II) is governed by attractive intermolecular Br...Br and Br...N interactions, which are also responsible for the very high density of (II) (1.861 Mg m(-3)).

SUBMITTER: Tongwa P

PROVIDER: S-EPMC2665971 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

1-Benzyl-3,5-bis-(2-thienylmethyl-ene)-4-piperidone.

Project description:In the title compound, C(22)H(19)NOS(2), the thio-phene rings form angles of 69.74?(18) and 65.56?(16)° with the benzene ring. The piperidone ring adopts a half-chair conformation due to the presence of the conjugated ketone systems. Both thio-phene rings are disordered over two orientations [occupancies of 0.758?(2)/0.242?(2) and 0.588?(2)/0.412?(2)] at 180° from one another. In the crystal, weak inter-molecular C-H?O hydrogen bonds, C-H?? and aromatic ?-? stacking inter-actions [shortest centroid-centroid separation = 3.865?(3)?Å] help to stabilize the packing.

| S-EPMC2970328 | biostudies-literature

(?-4-Bromo-3,5-dimethyl-pyrazolato-?(2)N(1):N(2))-?-chlorido-bis-[bis(4-bromo-3,5-dimethyl-pyrazole-?N(2))chloridocopper(II)] acetonitrile monosolvate.

Project description:In the title dinuclear complex, [Cu(2)(C(5)H(6)BrN(2))Cl(3)(C(5)H(7)BrN(2))(4)]·CH(3)CN, both Cu(II) ions are in slightly distorted square-pyramidal coordination geometries. The basal planes are defined by three N atoms from three 4-bromo-3,5-dimethyl-pyrazolate ligands, one of which is bridging, and one Cl ligand. A bridging Cl ligand forms the apical site for both Cu(II) ions. In the crystal, N-H?Cl hydrogen bonds connect complex mol-ecules into chains along [100]. Intra-molecular N-H?Cl hydrogen bonds are also observed.

| S-EPMC3344311 | biostudies-literature

3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis.

Project description:Dysregulated Notch signaling plays an important role in the progression of cancer. Notch signaling affects tumor growth and angiogenesis through the actions of its ligand Jagged-1. In this study, we developed a novel compound 3,5-bis(2,4-difluorobenzylidene)-4-piperidone (DiFiD) and determined that it inhibits cancer cell growth and its effects on Notch signaling. Intraperitoneal administration of DiFiD significantly suppressed growth of pancreatic cancer tumor xenografts. There was a reduction in CD31-positive blood vessels, suggesting that there was an effect on angiogenesis. In vitro, DiFiD inhibited the proliferation of various human and mouse pancreatic cancer cells while increasing activated caspase-3. Cell-cycle analyses showed that DiFiD induced G(2)-M arrest and decreased the expression of cell-cycle-related proteins cyclin A1 and D1 while upregulating cyclin-dependent kinase inhibitor p21WAF1. We next determined the mechanism of action. DiFiD reduced Notch-1 activation, resulting in reduced expression of its downstream target protein Hes-1. We further determined that the reduced Notch-1 activation was due to reduction in the ligand Jagged-1 and two critical components of the ?-secretase enzyme complex presenilin-1 and nicastrin. Ectopic expression of the Notch intracellular domain rescued the cells from DiFiD-mediated growth suppression. DiFiD-treated tumor xenografts also showed reduced levels of Jagged-1 and the ?-secretase complex proteins presenilin-1 and nicastrin. Taken together, these data suggest that DiFiD is a novel potent therapeutic agent that can target different aspects of the Notch signaling pathway to inhibit both tumor growth and angiogenesis.

| S-EPMC3213278 | biostudies-literature

Inhibition of the NF-?B signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.

Project description:Nuclear factor kappa B (NF-?B) is a key signaling molecule in the elaboration of the inflammatory response. Data indicate that curcumin, a natural ingredient of the curry spice turmeric, acts as a NF-?B inhibitor and exhibits both anti-inflammatory and anti-cancer properties. Curcumin analogs with enhanced activity on NF-?B and other inflammatory signaling pathways have been developed including the synthetic monoketone compound 3,5-Bis(2-fluorobenzylidene)-4-piperidone (EF24). 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31) is a structurally-related curcumin analog whose potency for NF-?B inhibition has yet to be determined. To examine the activity of EF31 compared to EF24 and curcumin, mouse RAW264.7 macrophages were treated with EF31, EF24, curcumin (1-100 ?M) or vehicle (DMSO 1%) for 1h. NF-?B pathway activity was assessed following treatment with lipopolysaccharide (LPS) (1 ?g/mL). EF31 (IC(50)~5 ?M) exhibited significantly more potent inhibition of LPS-induced NF-?B DNA binding compared to both EF24 (IC(50)~35 ?M) and curcumin (IC(50) >50 ?M). In addition, EF31 exhibited greater inhibition of NF-?B nuclear translocation as well as the induction of downstream inflammatory mediators including pro-inflammatory cytokine mRNA and protein (tumor necrosis factor-?, interleukin-1?, and interleukin-6). Regarding the mechanism of these effects on NF-?B, EF31 (IC(50)~1.92 ?M) exhibited significantly greater inhibition of I?B kinase ? compared to EF24 (IC(50)~131 ?M). Finally, EF31 demonstrated potent toxicity in NF-?B-dependent cancer cell lines while having minimal and reversible toxicity in RAW264.7 macrophages. These data indicate that EF31 is a more potent inhibitor of NF-?B activity than either EF24 or curcumin while exhibiting both anti-inflammatory and anticancer activities. Thus, EF31 represents a promising curcumin analog for further therapeutic development.

| S-EPMC3372981 | biostudies-literature

Methyl 3,5-bis(cyclo-hexyl-meth-oxy)benzoate.

Project description:In the title compound, C22H32O4, the atoms of the methyl ester group and the alk-oxy O atoms are all coplanar with the central aromatic ring, with an r.m.s. deviation of 0.008 Å. Bonds to the methyl-ene and cyclo-hexyl groups are also very close to this plane, so that the mol-ecule is essentially flat, apart from the cyclo-hexyl groups. The mean planes through the cyclo-hexyl groups are tilted by 30.08 (9) and 36.14 (7)° with respect to the central aromatic ring. In the crystal, pairs of mol-ecules linked by C-H⋯O hydrogen bonds form planar units which are stacked along the a axis, with an average inter-planar distance of 3.549 (2) Å. Stacking appears to be stabilized by further weak C-H⋯O hydrogen bonds.

| S-EPMC3998623 | biostudies-literature

Bis(2-bromo-5-methyl-phen-oxy)methane.

Project description:The complete mol-ecule of the title compund, C(15)H(14)Br(2)O(2), is generated by the application of crystallographic twofold symmetry, with the central C atom lying on the rotation axis. The dihedral angle between the benzene rings is 62.4 (3)°. In the crystal, short Br⋯Br contacts [3.4885 (16) Å] occur.

| S-EPMC3200963 | biostudies-literature

Crystal structures of methyl 3,5-di-bromo-4-cyano-benzoate and methyl 3,5-di-bromo-4-iso-cyano-benzoate.

Project description:The title crystals, C9H5Br2NO2, are the first reported 2,6-dihalophenyl cyanide-isocyanide pair that have neither three- nor two-dimensional isomorphism. Both crystals contain contacts between the carbonyl O atom and a Br atom. In the crystal of the cyanide, R22(10) inversion dimers form based on C?N?Br contacts, a common packing feature in this series of crystals. In the isocyanide, the corresponding N?C?Br contacts are not observed. Instead, the iso-cyano C atom forms contacts with the meth-oxy C atom. RNC was refined as a two-component pseudo-merohedral twin.

| S-EPMC5947800 | biostudies-other

3,5-Bis(3-methyl-imidazolium-1-ylmeth-yl)toluene bis-(hexa-fluoro-phosphate).

Project description:The asymmetric unit of the title N-heterocyclic carbene compound, C(17)H(22)N(4) (2+)·2PF(6) (-), consists of one N-heterocyclic carbene dication and two hexa-fluoro-phosphate anions. The two imidazole rings are twisted away from but to the same side of the central toluene ring, making dihedral angles of 76.69?(7) and 78.03?(7)° with the central ring. In the crystal, the components are linked by C-H?F interactions, generating a three-dimensional network.

| S-EPMC2983672 | biostudies-literature

Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).

Project description:3,5-Bis(2-fluorobenzylidine)-4-piperidone or EF24 is a potent anticancer derivative of curcumin. Using an amine derivative of EF24, we synthesized a hydrazinonicotinic acid conjugate, EFAH, for Tc-99m radiolabelling and single photon emission tomography imaging. The aqueous solubility of EFAH (3.5 mg/mL) was significantly more than that of EF24 (1.2 mg/mL); the octanol/water partition coefficient of EFAH was estimated at log P = 0.33. As an antiproliferative agent, EFAH was as effective as EF24 in suppressing the proliferation of H441, MiaPaCa-2 and Panc-1 cells. Daily intraperitoneal injection of EFAH (5 ?g) for 3 weeks in mice carrying xenografts of Panc-1 pancreatic cancer showed a mean tumour volume reduction of 79%; the tumour weight decreased by 82% in the treated group. For imaging and biodistribution, EFAH was labelled with Tc-99m (98% RCY) and intravenously administered in rats. Approximately 23.7% and 14.3% of injected dose accumulated in liver and intestine, respectively, suggesting that EFAH is mostly eliminated by hepatobiliary route. The results indicate that HYNIC modification of EF24 for Tc-99m radiolabelling does not affect its antiproliferative efficacy. For the first time, a visual biodisposition of EF24 in a live animal model has been demonstrated. Such knowledge could be of benefit in developing therapeutic curcuminoids, such as EF24.

| S-EPMC3272321 | biostudies-literature

1-Methyl-3,5-bis-[(E)-(3-methyl-2-thienyl)methyl-ene]piperidin-4-one monohydrate.

Project description:In the title mol-ecule, C(18)H(19)NOS(2)·H(2)O, the piperidine ring adopts an envelope conformation with the methyl substituent in an equatorial position. Each of the olefinic double bonds has an E configuration. The dihedral angle between the two thio-phene rings is 6.04 (14)°. The water mol-ecule forms two donor inter-actions, one with the carbonyl O atom and the other to the hetero N atom. The centrosymmetric {C(18)H(19)NOS(2)·H(2)O}(2) pairs thus formed are linked into a supra-molecular chain via C-H⋯O(water) contacts.

| S-EPMC2968964 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data